Azelaic Acid Foam + Azelaic Acid Gel
Phase 1Completed 0 watching 0 views this week💤 Quiet
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Papulopustular Rosacea
Conditions
Papulopustular Rosacea
Trial Timeline
Jan 1, 2011 → Mar 1, 2011
NCT ID
NCT01257919About Azelaic Acid Foam + Azelaic Acid Gel
Azelaic Acid Foam + Azelaic Acid Gel is a phase 1 stage product being developed by Bayer for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT01257919. Target conditions include Papulopustular Rosacea.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01257919 | Phase 1 | Completed |
Competing Products
18 competing products in Papulopustular Rosacea